Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells
Cisplatin is one of the most widely used anticancer drugs. Its side effects, however, have motivated researchers to search for equally effective analogs that are better tolerated. Selectively targeting cancer tissue is one promising strategy. For this purpose, a platinum(IV) complex was conjugated t...
| Main Authors: | , , , |
|---|---|
| Other Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier,
2015-09-22T17:34:07Z.
|
| Subjects: | |
| Online Access: | Get fulltext |